期刊文献+

蛋白脂质微粒体Saposin C-dops能增强小鼠免疫功能 被引量:1

Proteolipids microsomal Saposin C-dops can enhance immune function in mice
下载PDF
导出
摘要 目的:研究新型抗肿瘤药Saposin C-dops对小鼠免疫功能的影响。方法:采用实效药量及其10倍药量的Saposin C-dops给雌性B6小鼠进行连续7d腹腔注射给药后,检测小鼠脾脏中与肿瘤免疫相关的免疫细胞、血清中的细胞因子和IgG含量的变化,从而判断其在正常药量和超量情况下对健康小鼠免疫力的影响。结果:Saposin C-dops在正常用药量情况下对小鼠免疫功能有显著激活效应,这种激活效应不是剂量依赖的,而且在超量应用的情况下对小鼠免疫功能不产生负面影响。结论:Sapo-sin C-dops具有免疫激活剂的作用,能增强小鼠的免疫功能。 Objective To investigate the effect of the new-type antineoplastic agents Saposin C-dops on the immune function of mice. Methods Twenty-four female B6 mice were intraperitoneally injected with a regular and 10 times of the medication. We detected immune cells relating with oncologic immune in the spleen and immune factors in the serum, and determine its impact on the mouse immune system. Results Saposin C-dops activated the immune function of mice in a dose-independent manner, even over-dose did not have a negative impact on mice immune function. Conclusion Saposin C-dops,an immune activator,enhances the immunity of mice.
出处 《东南大学学报(医学版)》 CAS 2008年第6期418-421,共4页 Journal of Southeast University(Medical Science Edition)
基金 江苏省科学技术厅高技术研究(医药)重大项目(BG2007604)
关键词 Saposin C-dops 肿瘤免疫 免疫激活 小鼠 Saposin C-dops tumor immunity immune activation mice
  • 相关文献

参考文献18

  • 1KOLTER T, WINAU F, SCHAIBLE U E, et al. Lipid-binding proteins in membrane digestion, antigen presentation, and antimicrobial defense [ J ]. J Biol Chem,2005,280:41125-41128.
  • 2SANDHOFF K, KOLTER T. Topology of glycosphingolipid degradation[ J]. Trends Cell Biol, 1996,6:98-103.
  • 3VACCARO A M,SALVIOLI R,TATTI M,et al. Saposins and their interaction with lipids[J]. Neurochem Res ,1999 ,24 :307-314.
  • 4QI X Y, CHU Z T. Fusogenic domain and lysines in saposin C [ J]. Arch Biochem Biophys,2004,424:210-218.
  • 5QI X Y, GRABOWSKI G A. Differential membrane interactions of saposins A and C : implications for the functional specificity [ J]. J Biol Chem,2001,276 :27010-27017.
  • 6WANG Y,GRABOWSKI G A,QI X Y. Phospholipid vesicle fusion induced by saposin C [ J ]. Arch Biochem Biophys,2003, 415:43-53.
  • 7VAUPEL P, KALLINOWSKI F, OKUNIEF P. Blood flow,oxygen and nutrient supply and metabolic microenvironment of human tumor[ J]. Cancer Res, 1989,49:6449-6465.
  • 8ABU-BAKER S, QI X Y, NEWSTADT J ,et al. Structural changes in a binary mixed phospholipid bilayer of DOPG and DOPS upon saposin C interaction at acidic pH utilizing 31P and 2H solid-state NMR spectroscopy [ J ]. Biochim Biophys Acta, 2005,1717:58-66.
  • 9MORITA M, MOTOKI K, AKIMOTO K, et al. Structure-activity relationship of α-galactosylceramides against B16-bearing mice [ J]. J Med Chem, 1995,38:2176-2187.
  • 10NAKAGAWA R, MOTOKI K, UENO H, et al. Treatment of hepatic metastasis of the colon 26 adenocarcinoma with an α-galactosylceramide, KRN7000 [ J ]. Cancer Res, 1998, 58: 1202-1207.

二级参考文献7

  • 1孙淑英 顾学裘.脂质体作为抗癌抗生素载体的研究概况[J].沈阳药学院学报,1989,6:73-78.
  • 2RAHAMN A.Pharmacological,toxicological and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes[J].Cancer Res,1985,45:796-801.
  • 3JOHN N,WEINSTEIN J N.Liposomes as drug carriers in cancer therapy[J].Cancer Treat Rep,1984,68:1-4.
  • 4GABIZON A.Liposomes as in vivo carriers of adriamycin reduced cardiac uptake and preserved antitumor activity in mice[J].Cancer Res,1983,42:4734-4739.
  • 5VAN HOESEL Q G,ST TERENBERG P A,CROMMELIN D J,et al.Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes[J].Cancer Res,1984,44:3698-3702.
  • 6MAYHEW E,PAPAHADJOPONLOS D,RUSTUM Y,et al.Inhibition of cell growth in vitro and in vivo by 1-β-D-arabinofuranosylcytosine entrapped within phospholipid vesicles[J].Cancer Res,1976,36:4406-4410.
  • 7PARKER R J,HARTMAN K D,SIEBER S M.Lymphatic node adsorbtion and tissue distribution of liposomal encapsulated [14c] adriamycin following administration in rat[J].Cancer Res,1981,41:1311-1315.

共引文献2

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部